Literature DB >> 14564234

Critical pathways for acute myocardial infarction.

Christopher P Cannon1.   

Abstract

Critical pathways are standardized protocols for optimizing and streamlining patient care. They are important in the management of patients with acute myocardial infarction, many of whom do not receive evidence-based therapies. Several studies have demonstrated that the development and implementation of critical pathways that follow published guidelines and are tailored to the needs and resources of each institution result in increased use of evidence-based therapies, such as aspirin and beta-blockers, and is associated with decreased mortality. Use of these protocols has also been shown to reduce unnecessary therapy and under- or overutilization of certain procedures, thereby resulting in more cost-effective treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14564234

Source DB:  PubMed          Journal:  Rev Cardiovasc Med        ISSN: 1530-6550            Impact factor:   2.930


  4 in total

1.  Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy.

Authors:  Vesna Degoricija; Mirella Sharma; Ante Legac; Marina Gradiser; Sinisa Sefer; Zeljko Vucicević
Journal:  Croat Med J       Date:  2006-06       Impact factor: 1.351

2.  Effect of a Locally Tailored Clinical Pathway Tool on VBAC Outcomes in a Private Hospital in India.

Authors:  Nikita Kumari; Neeru Jain; Rinku Sen Gupta Dhar
Journal:  J Obstet Gynaecol India       Date:  2021-02-11

3.  The utility of clinical care pathways in determining perinatal outcomes for women with one previous caesarean section; a retrospective service evaluation.

Authors:  Sikolia Z Wanyonyi; Robinson N Karuga
Journal:  BMC Pregnancy Childbirth       Date:  2010-10-14       Impact factor: 3.007

4.  A comprehensive intervention following the clinical pathway of eating and swallowing disorder in the elderly with dementia: historically controlled study.

Authors:  Masahisa Arahata; Makoto Oura; Yuka Tomiyama; Naoe Morikawa; Hatsue Fujii; Shinji Minani; Yukihiro Shimizu
Journal:  BMC Geriatr       Date:  2017-07-14       Impact factor: 3.921

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.